A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- United Therapeutics
- Study ID
- NCT03683186
- Phase
- PHASE3
- Status
- Enrolling By Invitation
Conditions
- Cardiovascular Diseases
- Connective Tissue Diseases
- Familial Primary Pulmonary Hypertension
- Hypertension
- Hypertension, Pulmonary
- Lung Diseases
- PAH
- Pulmonary Arterial Hypertension
- Pulmonary Hypertension
- Respiratory Tract Disease
- Vascular Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Ralinepag — DRUGActive
Study Details
Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or Phase 3 study of ralinepag.
Key Dates
- Start date
- Sep 23, 2019
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 1,000 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: RalinepagRalinepag once daily extended-release tablets (oral) 50, 250, and 400 mcg titrated to the highest tolerated dose.
Primary Outcome Measure
Number of subjects with treatment-emergent adverse events [Safety and Tolerability] [ Time Frame: Up to 6 years ]
Locations (48)
Find similar trials in Phoenix, AZ
By condition
By specialty
By research site
Related Studies
- Diabetes and Heart Disease Risk in BlacksRecruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- Natural History of Stroke: Cause and DevelopmentRecruiting · National Institute of Neurological Disorders and Stroke (NINDS) · Washington D.C., District of Columbia
- Effect of Electro-Acupuncture on Blood PressureRecruiting · University of California, Irvine · Irvine, California
- TRANSCRIBE (Transcriptomic Analysis of Left Ventricular Gene Expression)Recruiting · Brigham and Women's Hospital · Boston, Massachusetts